LivaNova (LIVN) Gains from Investment Securities (2019 - 2026)
LivaNova's (LIVN) quarterly Gains from Investment Securities came in at -$151000.0 in Q2 2026, down 105.42% year-over-year from $2.8 million in Q2 2025, and down 101.42% quarter-over-quarter from $10.7 million in Q1 2026.
Powered by 
Analysis
LivaNova (LIVN) Gains from Investment Securities (2019 - 2026) Analysis & Trends
LivaNova has disclosed Gains from Investment Securities across 8 years of filings, most recently posting -$151000.0 for Q2 2026.
- In Q2 2026, Gains from Investment Securities fell 105.42% year-over-year to -$151000.0; the TTM figure through Jun 2026 stood at $14.7 million (up 116.97% YoY), while the FY2025 annual figure was $7.9 million, up 136.94% from the prior year.
- Gains from Investment Securities came in at -$151000.0 for Q2 2026 at LivaNova, down from $10.7 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $10.7 million in Q1 2026 to a low of -$23.6 million in Q2 2022.
- Average Gains from Investment Securities over 5 years is $64222.2, with a median of $1.3 million recorded in 2025.
- Year-over-year, Gains from Investment Securities sank 932.89% in 2022 and soared 2559.09% in 2025.
- Over 5 years, Gains from Investment Securities stood at $3.4 million in 2022, then soared by 40.73% to $4.8 million in 2023, then slumped by 38.52% to $3.0 million in 2024, then decreased by 19.64% to $2.4 million in 2025, then tumbled by 106.31% to -$151000.0 in 2026.
- Per Business Quant data, the three most recent Gains from Investment Securities figures were -$151000.0 in Q2 2026, $10.7 million in Q1 2026, and $2.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -151,000.00 |
| Mar 31, 2026 | 10.66 Mn |
| Dec 31, 2025 | 2.39 Mn |
| Sep 30, 2025 | 1.76 Mn |
| Jun 30, 2025 | 2.79 Mn |
| Mar 31, 2025 | 922,000.00 |
| Dec 31, 2024 | 2.98 Mn |
| Sep 30, 2024 | 66,000.00 |
| Jun 30, 2024 | 405,000.00 |
| Mar 31, 2024 | -133,000.00 |
| Dec 31, 2023 | 4.84 Mn |
| Sep 30, 2023 | -2.82 Mn |
| Jun 30, 2023 | 2.51 Mn |
| Mar 31, 2023 | 4.83 Mn |
| Dec 31, 2022 | 3.44 Mn |
| Sep 30, 2022 | -5.96 Mn |
| Jun 30, 2022 | -23.59 Mn |
| Mar 31, 2022 | -3.77 Mn |
| Dec 31, 2021 | -17.19 Mn |
| Sep 30, 2021 | 7.01 Mn |